Rheumatology expert witnesses

Rheumatologic conditions are among the most diagnostically demanding in internal medicine. Diseases such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, and systemic vasculitis present with symptoms that overlap with dozens of other conditions, evolve over months or years, and require a structured clinical reasoning process to diagnose correctly. When a patient suffers permanent joint damage, organ involvement, or functional disability because that process was bypassed, delayed, or incorrectly applied, the question of whether care fell below the accepted standard is rarely self-evident to a judge or jury. A rheumatology expert witness provides the clinical framework necessary to evaluate whether the treating physician's decisions — on ordering serologic tests, initiating disease-modifying therapy, making referrals, or monitoring for drug toxicity — were consistent with what a reasonably competent rheumatologist would have done. Without that framework, even well-documented departures from standard care can be difficult to convey persuasively.

The cases most frequently routed to rheumatology experts fall into several recurring categories. Delayed or missed diagnosis cases are the most prevalent, involving conditions that were attributed to mechanical joint disease, fibromyalgia, or non-specific inflammation when an autoimmune etiology was present and detectable. Medication management cases arise when a clinician fails to monitor for known toxicities of drugs such as hydroxychloroquine, methotrexate, or tumor necrosis factor inhibitors, or when a patient is not transitioned appropriately from corticosteroid therapy. Cases involving drug-induced lupus or autoimmune hepatitis triggered by a prescribed medication require a rheumatologist who can parse causation from the underlying disease course. Toxic-tort and occupational exposure cases — including silica, solvents, and certain industrial agents associated with systemic sclerosis or inflammatory arthritis — represent a distinct and technically demanding subset. Disability and workers' compensation matters frequently turn on functional capacity opinions that require an understanding of how inflammatory disease affects work performance over time.

Every rheumatology expert listed in the directory undergoes a structured review before the profile is made available to attorneys. Verification covers four primary areas. First, board certification is confirmed through the relevant certifying body's public records; the directory accepts certification in rheumatology granted through a recognized national board. Second, state medical license standing is checked in the jurisdiction where the expert holds an active license, and any disclosed board actions or restrictions are evaluated. Third, clinical activity is assessed: the directory prioritizes experts who are currently practicing or who have maintained clinical contact within a period sufficient to speak credibly to contemporary standards of care. Fourth, prior medico-legal engagement — including record review, written opinion, deposition, and trial testimony — is documented where available. Profiles that do not meet the threshold on any of these criteria are not activated.

A typical rheumatology expert engagement begins with a record review phase, during which the expert reviews the relevant medical records, laboratory results, imaging studies, and treating-provider notes to assess whether a departure from the standard of care occurred and, if so, whether it caused the claimed harm. This phase results in a preliminary opinion — sometimes delivered as a brief written summary, sometimes as a verbal report — that allows the retaining attorney to assess the strength of the case before committing to full retention. If the matter proceeds, the expert prepares a written report that articulates their methodology, the factual basis for their conclusions, and the clinical literature supporting their reasoning. Deposition preparation is a collaborative process; the expert should be prepared to explain complex immunologic or pharmacologic concepts in plain language, defend their differential diagnosis process, and respond to challenges based on alternative diagnostic interpretations. Trial testimony follows the same structure, with additional preparation focused on visual aids, demonstratives, and jury-accessible explanations of disease mechanisms.

Rheumatology opinions face reliability challenges in federal court under FRE 702 and the Daubert framework, and in state courts applying Frye or equivalent standards. The most common points of attack involve the expert's reliance on classification criteria — such as those developed by major rheumatology professional societies — in a diagnostic rather than classificatory context. Opposing counsel may argue that classification criteria are designed for research enrollment, not clinical diagnosis, and that applying them to establish breach of the standard of care conflates two distinct purposes. A well-prepared rheumatology expert understands this distinction and can explain how clinical diagnosis and classification criteria interact in practice. Challenges also arise around causation opinions in toxic-tort and drug-induced autoimmune cases, where the expert must demonstrate a methodology grounded in general acceptance within the rheumatology community, peer-reviewed literature, and a reliable application of that literature to the specific facts. Selecting an expert with documented experience navigating these challenges — evidenced by prior Daubert briefing or deposition testimony on methodology — reduces the risk of exclusion.